NEO-811-101 An Open-Label, First-in-Human, Phase 1/2 Dose Escalation and ExpansionStudy of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable ClearCell Renal Cell Carcinoma​

  • Phase I
  • Trial Category: Genitourinary

Contact(s)

Mary Beth Wilwerding, RN   Admin@NEcancertrials.com

Location(s)

Available at Nebraska Cancer Specialists, Omaha and Grand Island, NE locations

Interested in More Information?

Please fill out the form below. Someone will get back to you as soon as possible.

"*" indicates required fields

Name*